Prevention by dexrazoxane of down‐regulation of ryanodine receptor gene expression in anthracycline cardiomyopathy in the rat
Authors:
Open Access
- 1 September 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 131 (1) , 1-4
Abstract
Anthracyclines can cause cumulative dose‐related cardiotoxicity characterized by changes in Ca2+ metabolism, including dysfunction of the sacroplasmic reticulum (SR) and decreased expression of Ca2+‐handling proteins, such as the ryanodine receptor (RyR2). In this study, we examined the effect of dexrazoxane (ICRF‐187), an iron chelator which prevents anthracycline cardiotoxicity, on RyR2 gene expression in rats treated chronically with daunorubicin. Daunorubicin (2.5 mg kg−1 i.v. weekly for 6 weeks) produced cardiotoxicity as demonstrated by histopathologic changes. The ryanodine receptor/glyceraldehyde phosphate dehydrogenase (GAPDH) mRNA ratio was decreased by 38±3% (P−1; 1 h prior to each daunorubicin injection) prevented the decrease in RyR2/GAPDH mRNA ratio and histopathologic lesions in daunorubicin‐treated rats. This is the first report that a protective agent such as dexrazoxane can ameliorate the decreased expression of a specific gene involved in anthracycline‐induced cardiotoxicity.British Journal of Pharmacology (2000) 131, 1–4; doi:10.1038/sj.bjp.0703538Keywords
This publication has 13 references indexed in Scilit:
- Role of iron in anthracycline cardiotoxicity: new tunes for an old song?The FASEB Journal, 1999
- Redox Regulation of Cellular SignallingCellular Signalling, 1999
- The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein‐1 in cytosolic fractions from human myocardiumThe FASEB Journal, 1998
- Sarcoplasmic Reticulum Genes are Selectively Down-regulated in Cardiomyopathy Produced by Doxorubicin in RabbitsJournal of Molecular and Cellular Cardiology, 1998
- Sarcoplasmic reticulum in heart failure: central player or bystander?Cardiovascular Research, 1998
- Iron(II) Is a Modulator of Ryanodine-Sensitive Calcium Channels of Cardiac Muscle Sarcoplasmic ReticulumToxicology and Applied Pharmacology, 1995
- Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model.Journal of Clinical Investigation, 1993
- Timing of treatment with ICRF-187 and its effect on chronic doxorubicin cardiotoxicityCancer Chemotherapy and Pharmacology, 1993
- Effect of ICRF-187 pretreatment against doxorubicin-induced delayed cardiotoxicity in the ratToxicology and Applied Pharmacology, 1990
- The Anthracycline Antineoplastic DrugsNew England Journal of Medicine, 1981